US Edition
Cochlear Announces FDA Approval of Nucleus® Nexa™ Smart Cochlear Implant System | Hearing Health & Technology Matters
Summary by hearinghealthmatters.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Cochlear Announces FDA Approval of Nucleus® Nexa™ Smart Cochlear Implant System | Hearing Health & Technology Matters
LONE TREE, COLORADO — Cochlear Limited (ASX: COH) has received U.S. Food and Drug Administration (FDA) approval for the Cochlear Nucleus® Nexa System, described by the company as the world’s first and only smart cochlear implant system.³* Traditionally, cochlear implant recipients have accessed new features primarily through external sound processors. According to Cochlear, the Nucleus Nexa System introduces upgradeable firmware within the impla…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
